VYNE THERAPEUTICS INC VYNE 深 滬
交易中 09-20 14:35:59 美东时间
1.92
+0.020
+1.05%
華盛通- 最 高1.95
- 今 開1.88
- 成交量 2.13万股
- 最 低 1.88
- 昨 收 1.90
- 總市值 629.76万
- 52周最高 4.4808
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.57
- 委 比 29.58%
- 總股本 328.00万
- 歷史最高 2869.92
- 量 比 0.97
- 振 幅 3.68%
- 歷史最低 1.57
- 每 手 1
- 風險率 0.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多新浪财经ESG：VYNE 路孚特（Refinitiv）ESG评级调降至D+
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
07-30 07:04
快讯 | Vyne Therapeutics公司获得专利，涵盖了Vyn202计划中的化合物，有效期为20年，将于2042年6月到期。
Vyne Therapeutics Inc - Granted Patent Covers Compound in Vyne's Vyn202 Program...
07-16 20:03
Arvinas appoints Andrew Saik as CFO
Arvinas (NASDAQ:ARVN) on Monday announced the appointment of Andrew Saik to the role of Chief Financial Officer and Treasurer. Saik, most recently, served as CFO at Intercept Pharmaceuticals. Prior to...
06-25 04:41
Analysts’ Top Healthcare Picks: VYNE Therapeutics (VYNE), TriSalus Life Sciences (TLSI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
05-10 04:40
VYNE Therapeutics Presents VYN201 At 2024 SID Annual Meeting
Presentations will highlight positive preclinical and Phase 1b data of novel BET inhibitor, VYN201, in nonsegmental vitiligo
05-01 20:45
国家药监局关于发布仿制药参比制剂目录（第七十五批）的通告（2024年第6号）
转自：国家药监局 经国家药品监督管理局仿制药质量和疗效一致性评价专家委员会审核确定，现发布仿制药参比制剂目录（第七十五批）。 特此通告。 国家药监...
01-24 21:37
Top 5 Consumer Stocks That May Rocket Higher In Q1
The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
01-22 20:00
Crude Oil Falls Over 3%; Miromatrix Medical Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.14% to 32,788.73 while the NASDAQ rose 0.98% to 12,766.33. The S&P 500 also rose, gaining, 0.86% to 4,152.64.
2023-10-31 00:14
What's Going On With Coherus BioSciences Stock?
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares are trading higher Monday after the company announced the FDA-approval of Loqtorzi in all lines of treatment for
2023-10-30 23:04
